18168-Leukemia-AML-138

Leukemia

A Phase 3b, Single-Arm, Multicenter Open-Label Study of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in AML Patients Ineligible for Intensive Chemotherapy (M19-072)

  • Details

ClinicalTrials.gov ID: NCT03941964
Diagnosis Type: AML
USOR Number:

  • Address

6545 France Avenue, Suite 210
Edina, MN 55435
P: (952) 928-2900

Search by practice name, trial titles, indicators and specific disease types.